David K Carroll
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes (NCT07167693) | David K Carroll | 2025-12-19 |
Track David K Carroll automatically
Every clearance here is in the API, with alerts when new ones post.